Business Wire

CA-AKTANA

4.5.2022 13:57:13 CEST | Business Wire | Press release

Share
Almirall Deploys Aktana's Contextual Intelligence 360 to Optimize Customer Engagement

Aktana , the leader in intelligent customer engagement for the global life sciences industry, announced that Almirall, LLC selected its Contextual Intelligence Engine for nationwide rollout across two leading brands in the United States. The global skin health leader deployed Aktana’s solution in early January and is already outpacing expectations with 86% rep engagement and a sharp increase in rep productivity. Aktana’s Contextual Intelligence 360 is a modular solution that enables commercial and medical teams to rapidly scale AI-driven programs that personalize the customer experience, coordinate engagement, and optimize the entire HCP journey across channels.

With more than 300 deployments across 50+ use cases, Aktana has been refining its commercial life sciences intelligence platform for more than a decade. More than half of the world's top-20 pharmaceutical companies rely on Aktana to coordinate and optimize personalized omnichannel engagement with HCPs. With their recent deployment, Almirall now joins this group of industry innovators using Aktana’s modular AI solution to transform their commercial approach.

“We aim to be the global leader in medical dermatology and intend to act like a leader by replacing clunky processes with agile, best-in-class technologies,” said Vincent Cerio, head of commercial operations at Almirall. “We have seen swift and remarkable results. Our teams have embraced Aktana’s Contextual Intelligence 360 solution, seeing the impact on customer engagement and individual productivity. The rep locator module, for instance – which predicts how far HCPs will be from a rep’s expected location – has helped reps optimize their days, minimizing ‘windshield’ time.”

Change management is another critical aspect of AI adoption. Aktana incorporates change management functionality into its engine, such as seamless workflow integration and transparent suggestion logic, to build user confidence and accelerate onboarding. “At Aktana’s suggestion, we also invested in a formal change management program grounded in ongoing, honest communication. A team of early adopters provided feedback and served as internal champions, inspiring others to use Aktana’s system and experience the same benefits they were experiencing,” explained Cerio. “User acceptance has been great, so we want to expand our use of the system in various ways – from content optimization to next-best-action suggestions for our medical science liaisons.”

Contextual Intelligence 360 is powered by Aktana’s next-generation Contextual Intelligence Engine , which applies machine learning, explainable AI (xAI), human intelligence, and other advanced technologies to mine data and insights from all sources – from prescribing habits and patient demographics to past brand interactions and field rep insights. Dynamic, real-time recommendations ensure field and marketing teams work together to create meaningful HCP partnerships that continuously evolve.

“As a fast-growing medical dermatology company, Almirall recognizes the urgency and importance of leveraging advanced AI technology to empower its commercial teams,” said Derek Choy, president of Aktana. “With its flexible architecture, Aktana’s Contextual Intelligence 360 made it possible for Almirall to implement quickly while laying the foundation to scale into other areas and geographies when they’re ready to expand.”

About Aktana
Aktana is the category creator and leader of intelligent engagement in the global life sciences industry. By ensuring that every customer experience is tailored to individual preferences and needs, Aktana helps life science companies strengthen their relationships with healthcare providers to inspire better patient care. Today, commercial and medical teams from more than 300 brands use Aktana’s AI-enabled Contextual Intelligence Engine to coordinate and optimize personalized omnichannel engagement at scale. More than half of the top-20 global pharmaceutical companies are Aktana customers. Headquartered in San Francisco, Aktana has offices in every major biopharma region around the world. For more information, visit www.aktana.com .

Link:

ClickThru

Social Media:

https://facebook.com/aktanainc

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Xsolla Brings Direct-to-Consumer Commerce Expertise to Gamesforum Hamburg 2026 With Keynote and Panel Appearances9.6.2026 14:01:00 CEST | Press release

As An Exclusive Global Partner Of The Gamesforum Series, Xsolla Takes Two Stages In Hamburg, Headlined By A Keynote With AppsFlyer On Web Shop Attribution Xsolla, a global leader in video game commerce, today announced its participation in Gamesforum Hamburg 2026, taking place June 9–10, 2026, at NORD EVENT Panoramadeck in Hamburg, Germany. As an Exclusive Global Partner of the Gamesforum series, Xsolla will bring its direct-to-consumer commerce expertise to one of Europe's leading gatherings for mobile game growth and monetization, with Jane Startseva, Vice President of Business Development, EMEA, taking the stage across two sessions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260609166526/en/ Graphic: Xsolla Xsolla's presence in Hamburg underscores its role at the center of gaming's shift toward direct-to-consumer commerce: On June 9 at 10:00 AM, Jane joined Adam Smart, Global Director of Product – Gaming at AppsFlyer,

Duetti Expands Funding Offerings for Independent Artists With Two New Programs9.6.2026 14:01:00 CEST | Press release

Master Tracks as Young as Six Months Now Eligible for Acquisition Deals; New Remix Program Expands Collaboration Opportunities Duetti Inc. (“Duetti” or the “Company”), the music company that partners with independent artists and songwriters to buy, manage, and market their catalogs, announces today a significant expansion of its funding offering. Artists can now sell their master recording tracks, or parts thereof, in as little as six months after release - substantially earlier than the company’s prior two-year threshold. Duetti is also launching its new Remix Program, which allows independent artists to create remixes, covers, and other derivative works from Duetti’s 30,000-track catalog (across both masters and compositions). In return, artists can receive upfront cash compensation, ongoing royalty % share, 0% distribution fees, and dedicated marketing support. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260609063445/e

Clearlake Completes Strategic Acquisition of Pathway Capital Management9.6.2026 14:00:00 CEST | Press release

Expands Clearlake’s private markets solutions for institutional and private wealth marketsCombined platform represents over $185 billion in assets under management with more than 500 global employees Clearlake Capital Group, L.P. (“Clearlake” or the “Firm”), a global investment firm managing integrated platforms spanning private equity, liquid and private credit, and other related strategies, today announced the completion of its acquisition of Pathway Capital Management (“Pathway”), a global provider of private market solutions for institutional and wealth markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260609839186/en/ The strategic acquisition significantly expands Clearlake’s private markets platform, adding complementary capabilities and reinforcing its position as a leading diversified alternative asset manager. Founded in 1991, Pathway manages more than $95 billion in assets and brings a proven track record ac

Watchmaker to Unveil New Technologies Addressing NGS Workflow Bottlenecks and Sequencing Accuracy Challenges at ESHG 20269.6.2026 14:00:00 CEST | Press release

New technologies advance scalable library normalization for high-throughput genomics labs and improved amplification accuracy for oncology-focused sequencing workflows where data quality is critical Watchmaker Genomics, a leader in high-performance NGS workflow solutions, today announced it will unveil two new technologies at the European Society of Human Genetics (ESHG) 2026 conference, designed to address persistent bottlenecks in sequencing workflow scalability and amplification accuracy. The launches include the EquiPlex™ Normalization Kit, which simplifies library normalization using a novel Cas9-based approach, and Equinox® Prime Library Amplification Master Mix, engineered to improve indel accuracy in repetitive genomic regions while delivering superior amplification performance across sequencing applications. Built on Watchmaker’s expertise in protein engineering and integrated workflow design, the technologies reflect the company’s continued focus on solving real-world sequenc

The Open Group Releases OSDU® Data Platform Standard, Version 1.09.6.2026 14:00:00 CEST | Press release

The new standard provides a stable, interoperable foundation for data management across the energy ecosystem The Open Group, the global vendor‑neutral technology consortium, today announced the release of the OSDU® Data Platform Standard, Version 1.0. The new standard establishes a stable, clearly defined baseline for data platform capabilities, supporting greater interoperability, consistency, and confidence across the energy industry. The OSDU Data Platform Standard, Version 1.0 is designed to help organizations better manage, access, and use enterprise data by reducing fragmentation and breaking down data silos. It provides a common framework for organizing and accessing data securely and efficiently, supporting improved collaboration, innovation, and decision‑making. Key benefits of the standard include interoperability by design, increased stability for application development and deployment, and a clear foundation for certification. Operators benefit from greater choice and reduc

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye